This site is intended for healthcare professionals only
LoginRegister
Novartis opens new radioligand therapy manufacturing facility in CaliforniaCDSCO Panel Grants Novartis Protocol Amendment Proposal For Alpelisib
Novartis opens new radioligand therapy manufacturing facility in CaliforniaNovartis expands production of Pluvicto with addition of its largest, most advanced radioligand...
Boehringer Ingelheim, Kyowa Kirin enter into license agreement to develop fibro-inflammatory diseases treatmentBoehringer Ingelheim, Kyowa Kirin enter into license agreement to develop fibro-inflammatory...
Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in ChinaBoehringer Ingelheim, 3T Biosciences enter into second partnership for cancer immunotherapies
NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, DetailsNPPA fixes Retail Prices of 19 Formulations, Details
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchSubmit PK-PD data of 3 cohorts for 7 days: CDSCO Panel Tells Shilpa Medicare on Ondansetron ER Inj...
India orders new drug-making standards after overseas deathsIndia orders new drug-making standards after overseas deaths
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boomLilly launches end to end digital healthcare experience through LillyDirect
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck announces Phase 3 trial initiations for 4 investigational candidates from its hematology,...
AstraZeneca to Invest USD 15 Billion in China by 2030AstraZeneca Gets CDSCO Panel Nod to Study anti-cancer drug Dato-DXd and Durvalumab
GSK, Pfizer resolve patent lawsuit over RSV vaccinesBotox rival Revance loses bid to dismiss Allergan trade secrets lawsuit
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck seeks GLP-1 drugs with benefits beyond weight loss, says CEO
X